Abstract: The present invention relates to pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of cell proliferative diseases, inflammatory diseases, immunological diseases, cardiovascular diseases and infectious diseases. Furthermore, the present invention is directed towards pharmaceutical compositions containing at least one of the pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives and/or pharmaceutically acceptable salts thereof.

Abstract: The present invention is characterized in that coupling units are placed on upper and lower ends of the body of a conventional earphone, one coupling unit of respective coupling units is coupled, the earphone cord is wound between the coupling units, and the other coupling unit is coupled, thereby binding the earphone cord. The present invention makes it possible to prevent the cord from being twisted while being contained after earphone binding and to use the cord ring, which is created in the binding process, to hold the earphone on the user's body or a portable device.

Abstract: The present invention is characterized in that coupling units are placed on upper and lower ends of the body of a conventional earphone, one coupling unit of respective coupling units is coupled, the earphone cord is wound between the coupling units, and the other coupling unit is coupled, thereby binding the earphone cord. The present invention makes it possible to prevent the cord from being twisted while being contained after earphone binding and to use the cord ring, which is created in the binding process, to hold the earphone on the user's body or a portable device.